US OptionsDetailed Quotes
VKTX241206C63000
- 0.05
- -0.15-75.00%
15min DelayTrading Dec 2 11:54 ET
0.10High0.05Low
0.07Open0.20Pre Close18 Volume2.13K Open Interest63.00Strike Price109.00Turnover91.94%IV21.74%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0267Delta0.0122Gamma1035.80Leverage Ratio-0.0309Theta0.0002Rho27.69Eff Leverage0.0034Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet